Skip to main content
SpringerLink
Log in

Is there an optimal method for measuring baseline metabolic tumor volume in diffuse large B cell lymphoma?

  • Letter to the Editor
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ilyas H, Mikhaeel NG, Dunn JT, Rahman F, Moller H, Smith D, et al. Defining the optimal method for measuring baseline metabolic tumour volume in diffuse large B cell lymphoma. Eur J Nucl Med Mol Imaging. 2018. https://doi.org/10.1007/s00259-018-3953-z.

  2. Kanoun S, Tal I, Berriolo-Riedinger A, Rossi C, Riedinger JM, Vrigneaud JM, et al. Influence of software tool and methodological aspects of total metabolic tumor volume calculation on baseline [18F]FDG PET to predict survival in Hodgkin lymphoma. PLoS One. 2015;10:e0140830. https://doi.org/10.1371/journal.pone.0140830.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. Cottereau AS, Hapdey S, Chartier L, Modzelewski R, Casasnovas O, Itti E, et al. Baseline total metabolic tumor volume measured with fixed or different adaptive thresholding methods equally predicts outcome in peripheral T cell lymphoma. J Nucl Med. 2017;58:276–81. https://doi.org/10.2967/jnumed.116.180406.

    Article  PubMed  CAS  Google Scholar 

  4. Toledano MN, Desbordes P, Banjar A, Gardin I, Vera P, Ruminy P, et al. Combination of baseline FDG PET/CT total metabolic tumour volume and gene expression profile have a robust predictive value in patients with diffuse large B-cell lymphoma. Eur J Nucl Med Mol Imaging. 2018. https://doi.org/10.1007/s00259-017-3907-x.

  5. Sasanelli M, Meignan M, Haioun C, Berriolo-Riedinger A, Casasnovas RO, Biggi A, et al. Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphoma. Eur J Nucl Med Mol Imaging. 2014;41:2017–22. https://doi.org/10.1007/s00259-014-2822-7.

    Article  PubMed  CAS  Google Scholar 

  6. Cottereau AS, Lanic H, Mareschal S, Meignan M, Vera P, Tilly H, et al. Molecular profile and FDG-PET/CT total metabolic tumor volume improve risk classification at diagnosis for patients with diffuse large B-cell lymphoma. Clin Cancer Res. 2016;22:3801–9. https://doi.org/10.1158/1078-0432.CCR-15-2825.

    Article  PubMed  CAS  Google Scholar 

  7. Casasnovas O, Cottereau ASKS, Oberic L, Thieblemont C, Haioun C, et al. Baseline total metabolic voluem (TMTV0) predicts the outcome of patients with diffuse large B cell lymphoma (DLBCL) enrolled in the LNH07-3B LYSA trial. Hematol Oncol. 2015;33:100–80.

    Article  Google Scholar 

  8. Kostakoglu L, Martelli M, Sehn LH, Belada D, Carella AM, Chua N, et al. Baseline PET-derived metabolic tumor volume metrics predict progression-free and overall survival in DLBCL after first-line treatment: results from the phase 3 GOYA study. Blood. 2017;130:824.

    Google Scholar 

  9. Niyazi M, Landrock S, Elsner A, Manapov F, Hacker M, Belka C, et al. Automated biological target volume delineation for radiotherapy treatment planning using FDG-PET/CT. Radiat Oncol. 2013;8:180. https://doi.org/10.1186/1748-717X-8-180.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Meignan M, Sasanelli M, Casasnovas RO, Luminari S, Fioroni F, Coriani C, et al. Metabolic tumour volumes measured at staging in lymphoma: methodological evaluation on phantom experiments and patients. Eur J Nucl Med Mol Imaging. 2014;41:1113–22. https://doi.org/10.1007/s00259-014-2705-y.

    Article  PubMed  CAS  Google Scholar 

  11. Soret M, Bacharach SL, Buvat I. Partial-volume effect in PET tumor imaging. J Nucl Med. 2007;48:932–45. https://doi.org/10.2967/jnumed.106.035774.

    Article  PubMed  Google Scholar 

  12. Zijlstra JM, Boellaard R. Baseline PET as prognostic marker for Hodgkin? Blood. 2018;131:3–4. https://doi.org/10.1182/blood-2017-11-812958.

    Article  PubMed  CAS  Google Scholar 

  13. Quak E, Le Roux PY, Hofman MS, Robin P, Bourhis D, Callahan J, et al. Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patients. Eur J Nucl Med Mol Imaging. 2015;42:2072–82. https://doi.org/10.1007/s00259-015-3128-0.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, Cochin Hospital, Assistance Publique Hôpitaux de Paris, Paris Descartes University, 75014, Paris, France

    Anne-Ségolène Cottereau & Jérôme Clerc

  2. Imagerie Moléculaire In Vivo, CEA, Inserm, University Paris Sud, CNRS, Université Paris Saclay, Orsay, France

    Irene Buvat

  3. Nuclear Medicine Department, Institut Claudius Regaud, University Cancer Institute Toulouse Oncopole, Toulouse, France

    Salim Kanoun

  4. Santa Maria Nuova Hospital-IRCCS Reggio Emilia, Reggio, Italy

    Annibale Versari

  5. Department of Hematology, University Hospital F. Mitterrand and INSERM 1231, CHU Dijon, Dijon, France

    Olivier Casasnovas

  6. Department of Medical Physics, ‘Santa Croce e Carle’ Hospital, Cuneo, Italy

    Stephane Chauvie

  7. Research, Innovation and Statistics Department, Centre Antoine-Lacassagne, Nice, France

    Andrea Gallamini

  8. LYSA Imaging, Creteil, France

    Michel Meignan

Authors
  1. Anne-Ségolène Cottereau
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Irene Buvat
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Salim Kanoun
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Annibale Versari
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Olivier Casasnovas
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Stephane Chauvie
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jérôme Clerc
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Andrea Gallamini
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Michel Meignan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anne-Ségolène Cottereau.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cottereau, AS., Buvat, I., Kanoun, S. et al. Is there an optimal method for measuring baseline metabolic tumor volume in diffuse large B cell lymphoma?. Eur J Nucl Med Mol Imaging 45, 1463–1464 (2018). https://doi.org/10.1007/s00259-018-4005-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-018-4005-4

Search

Navigation